{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-116457","form_type":"8-K","ticker":"NNVC","cik":"0001379006","company_name":"NANOVIRICIDES, INC.","filed_at":"2025-11-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.264104+00:00","generated_at":"2026-05-16T16:26:39.959810+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"NanoViricides annual meeting approves director re-election, executive compensation, auditor ratification","bullets":["Anil Diwan re-elected as Class I Director with 9,757,652 votes in favor, 173,096 against.","Advisory vote on executive compensation passed: 9,500,223 for, 420,374 against.","Ratification of EisnerAmper as auditor for fiscal year ending June 30, 2026 passed: 14,594,257 for, 194,416 against.","Meeting held November 22, 2025; quorum of ~61% of outstanding voting capital stock present."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-116457","json":"https://secwatch.observer/filing/0001104659-25-116457.json","markdown":"https://secwatch.observer/filing/0001104659-25-116457.md","text":"https://secwatch.observer/filing/0001104659-25-116457.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1379006/000110465925116457/0001104659-25-116457-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1379006/000110465925116457/tm2531747d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T16:26:39.959810+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}